Categories: News

Icario and ConnectureDRX Partner to Deliver a Seamless Enrollment Experience for Medicare Advantage Members

Integration with Icario Connect enables agents to collect valuable insights during enrollment that improve satisfaction, member experience and early risk identification for new enrollees

MINNEAPOLIS, June 23, 2021 (GLOBE NEWSWIRE) — Icario, the healthcare industry’s largest health action company, today announced a new partnership with ConnectureDRX, the leading Medicare Advantage shopping and enrollment solution that provides consumers and agents with a superior experience for identifying which Medicare Advantage plan best fits their needs. Under the partnership, ConnectureDRX will integrate the Icario Connect platform to create a seamless experience for both agents and new members.

Most health plans wait to collect member data required to assess health risk and recommend supplement benefits until after the beneficiary becomes a member in the Medicare Advantage plan, leading to a cumbersome and clunky multi-step member engagement process.

The Icario-ConnectureDRX partnership streamlines the experience for members by allowing agents or consumers who enroll in Medicare Advantage plans using ConnectureDRX software to provide and collect valuable information at the time of enrollment, simplifying the process for both members and health plan teams while also providing plans with key clinical data that can be used for risk assessment.

“ConnectureDRX and Icario’s combined capabilities create a win-win situation for Medicare Advantage plans because it helps them collect critical information to enable them to improve the member experience, which impacts satisfaction ratings,” said Steve Wigginton, CEO of Icario. “The partnership provides instant value to our joint customers and also creates more attractive solutions for plans that need to boost risk assessment and member satisfaction.”

“We help millions of consumers each year shop for and enroll in Medicare Advantage plans, and this partnership with Icario will make the experience for those consumers even stronger,” said Grant Hoffman, executive vice president at ConnectureDRX. “The move creates in-house benefits as well, including more efficient workflows for enrollment teams, ultimately saving consumers, carriers, brokers and call centers even more time.”

About Icario
Icario is the leading health action company focused on connecting people to health. Icario uses pioneering behavioral research, data science and our adaptive multi-channel platform to deliver personalization at scale for the most trusted healthcare organizations in all 50 states, including eight of the 10 largest health plans. Learn more at www.icariohealth.com.

BOCA Communications for Icario
icario@bocacommunications.com

Staff

Recent Posts

NervGen Pharma Announces Proposed Amendment to Warrants

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB:…

10 hours ago

MyndTec Inc. Completes Ninth Tranche of Non-Brokered Private Placement

Mississauga, Ontario--(Newsfile Corp. - December 12, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"),…

12 hours ago

Dominari Holdings Announces Change of Record Date and Payment Date for $10 Million Cash Dividend

NEW YORK, Dec. 12, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) is pleased to announce…

12 hours ago

ISHI Health Launches Virtual Heart Failure Clinics in California and Arizona

SAN DIEGO, Dec. 12, 2025 /PRNewswire/ -- ISHI Health, an innovator in AI-enabled virtual cardiac…

12 hours ago

Zealthy Review 2026: How Zealthy Compares to FitRx and RoenRx for Weight Loss & GLP-1 Care

LOS ANGELES, CA / ACCESS Newswire / December 12, 2025 / The landscape of weight…

12 hours ago

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP)…

12 hours ago